Subscribe Sign In Register

Premium

Hedge Fund Titans Bet Big on Drugmaker Shire’s Success

John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux.

By Bailey McCann
December 8, 2016
2016-autumn-bailey-mccann-inside-the-trade-medical-article-page.jpg
Illustration by Renaud Vigor.

For the past few years, Shire has been defined by two things: popular niche drugs and failed M&A.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Lone Pine Capital Shire John Paulson Dan Loeb Suvretta Capital Management Marshall Wace Hedge Fund
Related
Cattle
Hedge Funds
Despite the Administration’s ‘Unconventional Approach,’ Dan Loeb Is Still Bullish for 2025
Stephen Taub
February 6, 2025
Financial growth graph. Sales increase, marketing strategy concept
Hedge Funds
The Return of Dan Loeb
Michelle Celarier
January 8, 2025
Bitcoin among gold bars
Sponsored
Gold and Bitcoin Decouple. What’s Driving the Divergence?